PL376796A1 - Sposób wytwarzania inhibitorów fosfodiesterazy-4 - Google Patents

Sposób wytwarzania inhibitorów fosfodiesterazy-4

Info

Publication number
PL376796A1
PL376796A1 PL376796A PL37679603A PL376796A1 PL 376796 A1 PL376796 A1 PL 376796A1 PL 376796 A PL376796 A PL 376796A PL 37679603 A PL37679603 A PL 37679603A PL 376796 A1 PL376796 A1 PL 376796A1
Authority
PL
Poland
Prior art keywords
phosphodiesterase
preparing inhibitors
inhibitors
preparing
Prior art date
Application number
PL376796A
Other languages
English (en)
Inventor
Jennifer Albaneze-Walker
Jerry Anthony Murry
Arash Soheili
Shawn A. Springfield
Original Assignee
Merck & Co., Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co., Inc. filed Critical Merck & Co., Inc.
Publication of PL376796A1 publication Critical patent/PL376796A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL376796A 2002-11-22 2003-11-18 Sposób wytwarzania inhibitorów fosfodiesterazy-4 PL376796A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42831502P 2002-11-22 2002-11-22
US47265503P 2003-05-22 2003-05-22

Publications (1)

Publication Number Publication Date
PL376796A1 true PL376796A1 (pl) 2006-01-09

Family

ID=32397111

Family Applications (1)

Application Number Title Priority Date Filing Date
PL376796A PL376796A1 (pl) 2002-11-22 2003-11-18 Sposób wytwarzania inhibitorów fosfodiesterazy-4

Country Status (14)

Country Link
US (1) US7312334B2 (pl)
EP (1) EP1565466A2 (pl)
JP (1) JP2006513271A (pl)
KR (1) KR20050085107A (pl)
AR (1) AR042194A1 (pl)
AU (1) AU2003291050A1 (pl)
BR (1) BR0316464A (pl)
CA (1) CA2506656A1 (pl)
HR (1) HRP20050450A2 (pl)
MX (1) MXPA05005405A (pl)
NZ (1) NZ539646A (pl)
PL (1) PL376796A1 (pl)
RU (1) RU2323938C2 (pl)
WO (1) WO2004048377A2 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080119509A1 (en) 2004-04-26 2008-05-22 Sophie-Dorothee Clas Altenrative Forms Of The Phosphodeisterase -4 Inhibitor N-Cyclopropyl-1- -3{3-[(1-Oxidopyryidin-3-Yl) Phenyl]-4-Oxo-1,4-Dihydro-1,8-Naphthyridine-3-Carboxyamide
EP2058310A4 (en) 2006-09-01 2010-11-17 Kyorin Seiyaku Kk PYRAZOLOPYRIDINCARBOXYL ACID AMID DERIVATIVE AND THE DERIVATIVELY PHOSPHODIESTERASE (PDE) INHIBITOR
AR066016A1 (es) * 2007-04-11 2009-07-15 Alcon Res Ltd Uso de un inhibidor del tnf alfa junto con una antihistamina para tratar la rinitis alergica y la conjuntivitis alergica
CA2773483A1 (en) * 2009-10-01 2011-04-07 Alcon Research, Ltd. Olopatadine compositions and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE757508A (fr) 1969-10-15 1971-04-14 Rieter Ag Maschf Procede pour la production d'un faisceau de fibres continu regulier et dispositif pour l'execution du procede
AR208414A1 (es) * 1974-11-07 1976-12-27 Rhone Poulenc Ind Procedimiento para obtener nuevos derivados de la((acil-4piperazinil-1)carboniloxi-5 pirrolinona-2)
ES2247325T3 (es) 2001-05-24 2006-03-01 MERCK FROSST CANADA & CO. Inhibidores de 1-biaril-1,8-naftiridin-4-ona fosfodiesterasa-4.
JO2311B1 (en) * 2001-08-29 2005-09-12 ميرك فروست كندا ليمتد Alkyl inhibitors Ariel phosphodiesterase-4

Also Published As

Publication number Publication date
WO2004048377A3 (en) 2004-09-02
US7312334B2 (en) 2007-12-25
AU2003291050A1 (en) 2004-06-18
CA2506656A1 (en) 2004-06-10
EP1565466A2 (en) 2005-08-24
AR042194A1 (es) 2005-06-15
RU2005119645A (ru) 2006-01-20
NZ539646A (en) 2008-03-28
WO2004048377A2 (en) 2004-06-10
JP2006513271A (ja) 2006-04-20
MXPA05005405A (es) 2005-08-03
BR0316464A (pt) 2005-10-11
US20060019981A1 (en) 2006-01-26
RU2323938C2 (ru) 2008-05-10
HRP20050450A2 (en) 2006-02-28
KR20050085107A (ko) 2005-08-29

Similar Documents

Publication Publication Date Title
GB0325192D0 (en) Method of use
GB0322989D0 (en) Method of deriving data
HK1077762A1 (zh) TFGß[轉化生長因子]的抑制劑
EP1603476A4 (en) PROCESS FOR REMOVING TATTOO
GB0308731D0 (en) Method of radiotherapy
ZA200403741B (en) Method of timberland management
SI1578695T1 (sl) Postopek za odstranitev biofilma
EP1577280A4 (en) DEUTERATION PROCESS
IL165475A0 (en) Nitrooxyderivatives of eyclooxygenase-2 inhibitors
GB0302572D0 (en) Method of treatment
GB0306309D0 (en) Method of treatment
EP1488046A4 (en) CONSTRUCTION METHODS
EP1512783A4 (en) KNITTING METHOD
PL376796A1 (pl) Sposób wytwarzania inhibitorów fosfodiesterazy-4
GB0208897D0 (en) New method of treatment
AU2003276825A8 (en) Method of immunotherapy
AP1845A (en) Method of demal protection
GB0213198D0 (en) Method of treatment
AU2003299623A8 (en) Method of making mercaptoalkylalkyldialkoxysilanes
GB0222736D0 (en) Method of authentication
GB0207091D0 (en) Method of treatment
GB0423692D0 (en) Method of communicating
PL351938A1 (en) Method of obtaining fructisiltransferase
GEU20041064U (en) Method for production of Matsoni
GB0315631D0 (en) Method of determination

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)